Keros Therapeutics, Inc. — DEF 14A Filings
5 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 5 DEF 14A documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001104659-25-037982 | Apr 23, 2025 | Jun 4, 2025 |
| DEF 14A | DEF 14A | 0001104659-24-048301 | Apr 17, 2024 | May 30, 2024 |
| DEF 14A | DEF 14A | 0001104659-23-048954 | Apr 24, 2023 | Jun 6, 2023 |
| DEF 14A | DEF 14A | 0001104659-22-046847 | Apr 18, 2022 | Jun 1, 2022 |
| DEF 14A | DEF 14A | 0001104659-21-051967 | Apr 19, 2021 | Jun 1, 2021 |